Name: 2023 for hVIVO
Uploaded: 2022-12-20T15:47:14.662024+00:00
Duration: 724 s
Channel: Vox Markets
Description: 2023 for hVIVO

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/005/618/005618/video_7XWcEyA.mp4#t=490

Vox Markets

2023 for hVIVO

Introduction

Year in Review 2022

Mo Khan CEO of hVIVO #HVO discusses some of their highlights in 2022, which includes contracted orders of £80m+, having a client base which includes four of the top 10 largest global biopharma companies and their name change. Mo also outlines his expectations for 2023

<p>Mo Khan CEO of hVIVO #HVO discusses some of their highlights in 2022, which includes contracted orders of £80m+, having a client base which includes four of the top 10 largest global biopharma companies and their name change. Mo also outlines his expectations for 2023</p>

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/005/618/005618/video_7XWcEyA.mp4